Cvrx inc (CVRX) - News Archive

CVRx Publishes New Data Showcasing Long-Term Quality of Life Benefits of Barostim in Heart Failure Patients CVRx Inc. (NASDAQ: CVRX) has announced the publication of new data highlighting the long-term benefits of its i...

In a significant development for the cardiovascular medical device landscape, CVRx, Inc. (NASDAQ: CVRX) announced on August 2, 2024, that the Centers for Medicare and Medicaid Services (CMS) has redefined payment parame...

Heart failure affects millions of individuals worldwide and is associated with significant morbidity and mortality rates. Despite advances in medical management, many patients experience persistent symptoms and reduced...

CVRx, a leading medical technology company, has recently attained FDA approval for expanded labeling of its innovative Barostim therapy. This development marks a significant milestone in the field of cardiac healthcare,...